New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 20, 2014
08:02 EDTWXWuXi PharmaTech's Suzhou toxicology facility passes FDA inspection
WuXi PharmaTech announced that its toxicology facility in Suzhou recently passed a surveillance Good Laboratory Practice inspection by the FDA with no major observations. This was the first FDA GLP inspection in the facility's five years of operation. The inspection was extensive, lasting five days and including the review of numerous processes and the audit of four studies. WuXi's toxicology facility in Suzhou has completed 92 IND-enabling programs for global submissions.
News For WX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
05:33 EDTWXWuXi PharmaTech downgraded to Hold from Buy at Jefferies
Jefferies downgraded WuXi PharmaTech to Hold with a $38 price target saying upcoming margin pressure is not priced into shares or reflected in consensus estimates.
November 12, 2014
16:36 EDTWXWuXi PharmaTech narrows FY14 EPS view to $1.83-$1.86 from $1.82-$1.86
Subscribe for More Information
16:33 EDTWXWuXi PharmaTech sees Q4 EPS 50c-53c, consensus 57c
Subscribe for More Information
16:32 EDTWXWuXi PharmaTech reports Q3 EPS 54c, consensus 48c
Subscribe for More Information
15:29 EDTWXNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use